US90138F1021 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 2.842B 61.30% | 3.826B 34.64% | 4.154B 8.56% | 4.456B 7.27% | |||||||
EBITDA YoY % growth | -626.02M -93.07% | -751.77M -20.09% | -82.99M 88.96% | 838.82M 1,110.75% | N/A | N/A | N/A | N/A | |||
EBIT YoY % growth | -884.4M -86.62% | -1.031B -16.56% | -367.403M 64.36% | 600.9M 263.55% | N/A | N/A | N/A | N/A | |||
Operating Margin | -31.12% | -26.94% | -8.84% | 13.49% | N/A | N/A | N/A | N/A | |||
EPS YoY % growth | -0.25 -208.70% | -0.16 36.00% | 2.45 1,631.25% | 2.76 12.81% |
All data in USD
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 0.61 29.15% | |||||||||||
Revenue Q2Q % growth | 1.053B 4.61% | |||||||||||
EBITDA Q2Q % growth | 190.3M | |||||||||||
EBIT Q2Q % growth | 130.51M 208.49% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 0.86 290.91% | 0.59 | 0.27 | 45.48% |
Q3 2023 Q2Q % growth | 0.58 314.81% | 0.36 | 0.22 | 60.49% |
Q2 2023 Q2Q % growth | 0.54 590.91% | 0.31 | 0.23 | 74.89% |
Q1 2023 Q2Q % growth | 0.47 ∞% | 0.21 | 0.26 | 122.75% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 1.076B 5.01% | 1.064B | 11.95M | 1.12% |
Q3 2023 Q2Q % growth | 1.034B 5.16% | 1.009B | 24.7M | 2.45% |
Q2 2023 Q2Q % growth | 1.038B 10.01% | 1.006B | 31.8M | 3.16% |
Q1 2023 Q2Q % growth | 1.007B 14.99% | 1.024B | -17.4M | -1.70% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -0.06% | 10.55% | 1.24% | 11.53% |
Revenue | 0% | -1.77% | 0.38% | -1.22% |